Log In
BCIQ
Print this Print this
 

HIV vaccine (gp120/tat/nef)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHIV vaccine utilizing HIV gp120, tat and nef proteins as immunogens
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection/AIDS
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today